| Association Between Alcohol Consumption and Disability Accumulation in Multiple Sclerosis J Wu, T Olsson, JA Hillert, L Alfredsson, AK Hedström Neurology: Neuroimmunology & Neuroinflammation 11 (5), e200289, 2024 | | 2024 |
| A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis M Pahlevan Kakhki, A Giordano, C Starvaggi Cucuzza, ... Nature Communications 15 (1), 6419, 2024 | | 2024 |
| Concomitant autoimmunity and risk of multiple sclerosis disability worsening S Binzer, J Hillert, A Manouchehrinia Multiple Sclerosis and Related Disorders 87, 105637, 2024 | | 2024 |
| COMBAT‐MS: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab F Piehl, P Alping, S Virtanen, S Englund, J Burman, K Fink, ... Annals of Neurology, 2024 | | 2024 |
| The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care–updates at the 2023 plenary event P Zaratin, S Samadzadeh, M Seferoğlu, V Ricigliano, J dos Santos Silva, ... Frontiers in Neurology 15, 1407257, 2024 | | 2024 |
| Socioeconomic status and quality of multiple sclerosis care in Sweden A He, A Manouchehrinia, A Glaser, H Butzkueven, O Ciccarelli, J Hillert, ... Multiple Sclerosis and Related Disorders, 105726, 2024 | | 2024 |
| Big Multiple Sclerosis Data network: an international registry research network A Glaser, H Butzkueven, A van der Walt, O Gray, T Spelman, C Zhu, ... Journal of Neurology 271 (6), 3616-3624, 2024 | 1 | 2024 |
| Exploring the working life of people with multiple sclerosis during the COVID-19 pandemic in Sweden C Murley, J Dervish, A Machado, V Svärd, A Wennman-Larsen, J Hillert, ... BMC Public Health 24 (1), 1389, 2024 | | 2024 |
| Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis J Huang, K Tengvall, I Bomfim Lima, AK Hedström, J Butt, N Brenner, ... Brain, awae110, 2024 | 3 | 2024 |
| Treatment Persistence of Cladribine Tablets Versus Other Oral Disease-modifying Treatments for Multiple Sclerosis: Results from Danish, Norwegian, and Swedish Registries (P10-6 … T Spelman, JH Aarseth, E Celius, S Wergeland, M Magyari, E Framke, ... Neurology 102 (17_supplement_1), 3314, 2024 | | 2024 |
| Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies C Murley, E Pettersson, J Hillert, A Machado, E Friberg Multiple Sclerosis Journal–Experimental, Translational and Clinical 10 (2 …, 2024 | | 2024 |
| Clinical characteristics and long-term outcomes of late-onset multiple sclerosis: A Swedish nationwide study EF Mouresan, E Mentesidou, A Berglund, KA McKay, J Hillert, ... Neurology 102 (6), e208051, 2024 | 5 | 2024 |
| Expert opinion on the use of contraception in people with multiple sclerosis J Hillert, R Bove, LB Haddad, K Hellwig, M Houtchens, M Magyari, ... Multiple Sclerosis Journal, 13524585241228103, 2024 | | 2024 |
| Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in Sweden FS Teni, A Machado, K Fink, H Gyllensten, J Hillert, E Friberg Multiple Sclerosis Journal 30 (3), 419-431, 2024 | 1 | 2024 |
| Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force T Parciak, L Geys, A Helme, I van der Mei, J Hillert, H Schmidt, A Salter, ... Multiple Sclerosis Journal 30 (3), 396-418, 2024 | 2 | 2024 |
| Risk of multiple sclerosis in people living with HIV: an international cohort study KA McKay, JMA Wijnands, A Manouchehrinia, F Zhu, P Sereda, J Li, M Ye, ... Annals of Neurology 95 (3), 487-494, 2024 | 4 | 2024 |
| Fine-mapping genomic loci refines bipolar disorder risk genes M Koromina, A Ravi, G Panagiotaropoulou, BM Schilder, J Humphrey, ... medRxiv, 2024 | | 2024 |
| Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy E Longinetti, S Englund, J Burman, K Fink, A Fogdell-Hahn, ... Journal of Neurology, Neurosurgery & Psychiatry 95 (2), 134-141, 2024 | 3 | 2024 |
| Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis J Ingvarsson, V Grut, M Biström, LP Berg, P Stridh, J Huang, J Hillert, ... European journal of neurology, e16387, 2024 | | 2024 |
| Yolanda Aladro, European University of Madrid, Spain LL Pascual, IR Zarbo, P Zaratin, P Zaratin, S Samadzadeh, M Seferoğlu, ... | | 2024 |
